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Loss of lymphatic vessels and regional lipid
accumulation is associated with great saphenous
vein incompetence
Hiroki Tanaka, MD,a,b,c Nobuhiro Zaima, PhD,b,d Takeshi Sasaki, PhD,e Naoto Yamamoto, MD,a,c
Masaki Sano, MD,a,c Hiroyuki Konno,MD,c Mitsutoshi Setou, MD,b andNaoki Unno,MD,a,c Hamamatsu and
Nara, Japan
Objective:Recent studies suggest that biologic changes in the vein wall associated with varicose veins (VVs) occur not only
in valvular tissue but also in nonvalvular regions. We previously used imaging mass spectrometry (IMS) to determine the
distribution of lipid molecules in incompetent valve tissue. In this study, we used IMS to analyze incompetent great
saphenous veins (GSVs) in patients with varicose vein (VV) to assess the distribution of lipid molecules.
Methods: We obtained GSV tissue from 38 VV patients (50 limbs) who underwent GSV stripping. For the control veins
(CV), we obtained GSV samples from 10 patients undergoing infrainguinal bypass with reversed GSV grafting for
peripheral artery occlusive disease (10 limbs). Conventional and immunofluorescence staining were performed for
histopathologic examination. The total lipid content in the homogenized vein tissue was determined. The localization of
each lipid molecule in the vein wall was assessed by IMS.
Results: The histologic examination showed the VV walls were significantly thicker than the CV walls, and only the VV
adventitia was positive for lipid staining. The VV wall had higher concentrations of phospholipids and triglycerides than
the CV wall. IMS revealed an abnormal accumulation of lysophosphatidylcholine (LPC; 1-acyl 16:0) and phosphatidyl-
choline (diacyl 16:0/20:4) in the VV intima and media. Triglyceride was found only in VV adventitia. The number of
lymphatic vessels, as measured by staining with D2-40, a lymphatic vessel-specific marker, was significantly lower in the
VV adventitia than in the CV adventitia. Lymphatic vessel reduction may be associated with insufficient lymphatic
drainage in the VV adventitia causing histologic changes in VV tissue.
Conclusions:TheaccumulationofLPC(1-acyl16:0) andPC(diacyl16:0/20:4) in theVVintimaandmediamaybeassociatedwith
chronic inflammation, leading to VV tissue degeneration. Furthermore, insufficient lipid drainage by lymphatic vessel may be
responsible for accumulation of lipid molecules and subsequent vein wall degeneration. (J Vasc Surg 2012;55:1440-8.)
Clinical Relevance: Abnormal distribution of lipid molecules in varicose vein (VV) tissue in patients at CEAP class C2-3
and C4-5 suggests that VV-associated accumulation of lipid molecules begins in the early clinical stages of the disease and
continues through the advanced stages. In particular, the accumulation of both lysophosphatidylcholine (1-acyl 16:0)
and phosphatidylcholine (diacyl 16:0/20:4) in the media was significantly higher in VV tissue from patients in advanced
clinical stages, suggesting an association between lipid accumulation and chronic inflammation of skin and subcutaneous
tissues. Further study is needed to clarify the effect of lymph stasis on VVs and chronic inflammation. The mechanism
whereby adventitial lymphatic vessels are damaged is also unknown. Consistent venous hypertension and subsequent
overload to the lymphatics may account for the lymphatic damage. In addition, accumulation of possible proinflamma-
tory lipid molecules in VV walls may further damage the adventitial lymphatic vessels.
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1440We previously determined the characteristic distribu-
ion of lipid molecules in regions surrounding incompetent
alves in patients with varicose veins (VVs) by using imag-
ng mass spectrometry (IMS).1 IMS revealed the accumu-
ation of lysophosphatidylcholine (LPC; 1-acyl 16:0) and
hosphatidylcholine (PC; diacyl 16:0/20:4) in the valvular
egion. Because thesemolecules are potential proinflamma-
ory lipids,2-4 this finding suggests that LPC and PC are
nvolved in the development of tissue inflammation and
alvular incompetence. These results support previously
eported data.5,6 However, recent studies suggest that his-
ologic changes in the wall of the great saphenous vein
GSV) may precede valvular dysfunction.5 The pathogen-
sis of these biologic changes is yet to be elucidated.
nvestigation of the lipid profile of the GSV wall may help
ain insight into the influence of dyslipidemia in the VV
issues. For this purpose, we used IMS to analyze the
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patients.
METHODS
All procedures used in this study were approved by the
Ethics Committee of Clinical Research of the Hamamatsu
University School of Medicine.
Sample collection. We enrolled 48 patients in this
study between April 2008 and December 2010. We ob-
tained GSV tissue from of 38 VV patients (50 limbs) who
underwent GSV stripping. Clinical information is summa-
rized in Table I. By CEAP clinical severity scores,7 16
samples were assigned to C2 (simple VV), 11 to C3 (VV
with ankle swelling), 21 to C4 (VV with skin changes), and
2 to C5 (VV with healed ulcer). To investigate the associ-
ation between the tissue lipid profiles and disease severity,
we classified the VV patients into two groups: C2-3 (mod-
erate VV group) and C4-5 (severe VV group). As control
veins (CV), segmental GSV tissues were harvested from 10
patients (10 limbs) with peripheral artery occlusive disease
who underwent infrainguinal bypass with reversed GSV
grafting (Table I).
To maintain tissue morphology and minimize molecu-
lar degradation, tissue samples were immediately frozen in
liquid nitrogen and stored at –80°C until matrix-assisted
laser desorption–ionization IMS (MALDI-IMS) analysis;
other samples were preserved in 10% formalin for histo-
pathologic examination.
All patients underwent duplex ultrasound scans with a
7.5-MHz transducer (LOGIC 500; GE Yokogawa Medi-
cal, Tokyo, Japan) to assess venous hemodynamics. Clinical
disease severity was graded using the standard CEAP clas-
sification according to the recommendations of an Interna-
tional Consensus Committee on Chronic Venous Disease.7
Venodynamic studies were performed using duplex scan-
ning, with patients scanned while standing to assess reflux
throughout the GSV. Reflux was defined as flow in the
reverse direction of the physiologic flow of duration 0.5
seconds after a provocation maneuver.8 All VV patients had
Table I. Demographic and clinical data for each group of
Variablea Control veins
Limbs 10
Sex
Men 9
Women 1
Age, years 65.9  11.4
Disease duration, years . . .
Cholesterol, mg/dL
Total 191.3  43.3
LDL 121.3  22.7
HDL 39.2  15.2
Triglyceride, mg/dL 108.3  51.2
Hemoglobin A1C, % 6.0  1.9
HDL, High-density lipoprotein; LDL, low-density lipoprotein.
Categoric data are expressed as number and continuous data as mean  staretrograde flow in the saphenofemoral junction; the con- arol patients had no reflux in the GSV. We analyzed the
SV tissue that was in close to the saphenofemoral junc-
ion, excluding the terminal valve.
Imaging mass spectrometry. We cut the frozen tis-
ues into 8-m-thick longitudinal sections using a cryostat
CM1950; Leica, Wetzler, Germany). Sections were thaw-
ounted onto indium tin oxide–coated glass slides (Bruker
altonics, Bremen, Germany) and dried at room tempera-
ure. A total of 500 L of 2,5-dihydroxybenzoic acid
olution (50 mg/mL in methanol/water, 7:3 [v/v]) was
prayed on the sample sections using a 0.2-mm nozzle
irbrush (Procon Boy FWA Platinum; Mr. Hobby, Tokyo,
apan). A 15-cm distance was maintained between the
ozzle and the tissue surface during spraying.
We performed IMS using a MALDI time of flight
TOF)/TOF-type instrument (Ultraflex II TOF/TOF;
ruker Daltonics, Bremen, Germany) equipped with a
55-nm neodymium-doped yttrium aluminium garnet la-
er (repetition rate, 200 Hz). Data were acquired with a
tep size of 50 m for the samples in the positive ion mode
reflector mode). The mass spectrometer parameters were
et to obtain the highest sensitivity with mass/charge ratio
m/z) values of 400 to 1000. All spectra were acquired
utomatically using Flex Imaging software (Bruker Dalton-
cs). The laser was used to irradiate each position 100 times.
he peaks were normalized to the total ion current and
hen compared. Ion images were created using Flex Imag-
ng software (Bruker Daltonics).
Tandem MS. Tandem MS (MS/MS) was performed
n tissue sections using a linear quadruple ion trap
TQ-XL mass spectrometer (Thermo Fisher Scientific,
altham Mass), as described previously.9 Precursor and
ragment ions obtained by collision-induced dissociation
ere ejected from the ion trap and analyzed. Collision
nergy was set to 30% (this unit is customized for LTQ-XL;
00% indicates the energy that completely fragments the
eptide Met-Arg-Phe-Ala). The laser energy was set to 30
J. Specific fragment patterns of triglycerides (TGs), LPC,
nts
C2-3 C4-5
27 23
5 4
17 12
62.8  13.8 64.7  15.1
13.4  11.7 17.8  16.9
186.7  41.9 182.2  45.2
116.6  31.6 117.5  34.2
43.1  12.8 41.0  12.3
113.1  24.1 112.5  32.2
5.9  1.2 5.8  2.5
deviation.patiend PC were confirmed using previous reports.1,3,10-12
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May 20121442 Tanaka et alHistopathologic examinations. Specimens for light
microscopy were fixed in 10% neutral-buffered formalin
solution and were processed to prepare 4-mm-thick paraf-
fin sections. Sections were stained with hematoxylin and
eosin (HE) and elastica van Gieson (EVG). A light micro-
scope was used for quantitative measurements.
Biochemical quantitation. Total lipids were ex-
tracted from homogenized tissue as described previously.13
Phospholipids and TGs were quantified using colorimetric
methods (Wako, Osaka, Japan).
Immunostaining. Tissue sections (8 m) were fixed
with 4% paraformaldehyde in phosphate-buffered saline
(pH 7.4) for 10 minutes at room temperature. Sections
were rinsed with phosphate-buffered saline, preincubated
with 10% normal goat serum (Nichirei Biosciences, Tokyo,
Japan), and incubated overnight at 4°C with rabbit anti-
von Willebrand factor (1:400; Acris Antibodies GmbH,
Herford, Germany) and mouse anti-D2-40 (1:200; Acris
Antibodies GmbH,Herford, Germany). Immunoreactivity
was visualized using Alexa Fluor 488-conjugated antirabbit
immunoglobulin G and Alexa Fluor 594-conjugated anti-
mouse immunoglobulin G (Molecular Probes; Invitrogen,
Carlsbad, Calif). All Alexa Fluor-conjugated secondary an-
tibodies were diluted 200-fold for use. The slides were
mounted in a glycerol-based Vectashield medium (Vector
Laboratories, Burlingame, Calif) containing the nucleus
staining reagent 4=,6-diamidino-2-phenylindole.
Statistical analysis. Results have been summarized
using descriptive statistics. All data are expressed as mean
standard deviation. The significance of the differences be-
tween groups with respect to vein wall thickness, lipid
content, ratio of intensity, and the number of lymphatic
vessels was determined by one-way analysis of variance,
followed by the Tukey test. A value of P  .05 was consid-
ered significant. All statistical analyses were performed with
StatView 5.0 software (SAS Institute, Tokyo, Japan).
RESULTS
Clinical information. Patient demographics are re-
Fig 1. Thickness of the great saphenous vein wall. The
(right) adventitia layers is compared among the control
groups. *P  .05 indicates a statistically significant differported in Table I. The control and C2-3, and C4-5 VV droups did not differ significantly in age, disease duration,
erum total cholesterol, serum low-density lipoprotein
LDL), serum high-density lipoprotein (HDL), serum TG
ontents, and hemoglobin A1C. The only significant differ-
nce between groups was the sex ratio.
Histopathologic examinations. The intimal thick-
ess of VV tissue in the C2-3 and C4-5 groups was 1.9-fold
nd 2.1-fold greater, respectively, than that in the CV tissue
P  .01; Fig 1). The medial thickness of VV tissue in
roups C2-3 and C4-5 was 1.2-fold and 1.3-fold greater,
espectively, than that in CV tissue, (P  .01; Fig 1). The
dventitial thickness of VV tissue in groups C2-3 and C4-5
as 1.8-fold and 2.1-fold greater, respectively, than that of
he CV tissue (P  .05; Fig 1).
Lipid staining and quantification. In lipid staining
ith oil red O, the adventitia of the VV tissue showed
ositive staining, but other regions, such as the intima and
edia, were not positively stained (Fig 2, A). In contrast,
o regions of the CV tissue showed positive staining (Fig 2,
). These results suggested an unknown mechanism of
ipid accumulation in the adventitial tissue of the VV tissue.
he PL content in groups C2-3 and C4-5 was higher by
.8-fold and 1.7-fold, respectively, than in CV tissue (P 
01; Fig 2, B). In addition, the TG content in groups C2-3
nd C4-5 was higher by 2.1-fold and 2.5-fold, respectively,
han in the CV tissue (P .01; Fig 2, B). The experimental
roups did not differ in PL and TG contents (Fig 2, B).
Imagingmass spectrometry. We investigated the dis-
ribution pattern of lipids in CV and VV tissues using
ALDI-IMS (Fig 3,A). On gross inspection, there was no
otable difference in the patterns between the control and
V groups. Among the spectrum patterns, we paid atten-
ion to seven peaks: m/z 496, 782, 798, 804, 820, 879,
nd 881, which were determined to correspond to LPC
1-acyl 16:0)H, PC (diacyl 16:0/18:1)Na, PC (diacyl
6:0/18:1)K, PC (diacyl 16:0/20:4)K, TG (52:3)
and TG (52:2)  K, respectively, based on MS/MS and
revious reports using IMS (Table II).
Further analysis using MALDI-IMS revealed that the
red thickness of the (left) intima, (middle) media, and
(CV) and varicose veins from the CEAP C2-3 and C4-5
. The error bars show the standard deviation.measu
veinistribution of LPC (1-acyl 16:0), PC (diacyl 16:0/20:4),
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Volume 55, Number 5 Tanaka et al 1443TG (52:3), and TG (52:2) in VV tissue differed between
each tissue, whereas PC (diacyl 16:0/18:1) was detected
ubiquitously in all tissues (Fig 3, B). Accumulation of LPC
(1-acyl 16:0) and PC (diacyl 16:0/20:4) was found in the
VV intima and media. In contrast, accumulation of TG
(52:3) and TG (52:2) was found in VV adventitia. How-
ever, the distribution patterns of LPC (1-acyl 16:0), PC
(diacyl 16:0/20:4), and TG (52:3) and TG (52:2) were
similar in the two experimental groups (Fig 3, B).
Fig 3, C shows quantitative comparisons of LPC (1-
acyl 16:0), PC (diacyl 16:0/18:1), PC (diacyl 16:0/20:4),
and TG (52:3) and TG (52:2) in the intima, media, and
adventitia between CV, C2-3 and C4-5 tissue as expressed to
be a ratio of relative intensity (RRI). RRI was calculated as
follows. We designated the intima, media, and adventitia in
the region analyzed by IMS as covering the total of ion
intensities. The ion intensity obtained from each tissue was
not the absolute value. Therefore, each molecule’s ion
intensity was standardized to that of PC (16:0/18:1) as
expressed to be a RRI. PC (16:0/18:1) was widely available
for the internal standard molecule at mammalian tissue
analysis by IMS.
There were no differences in the RRIs for PC (diacyl
16:0/18:1) among these regions (data not shown). In
contrast, the RRIs for LPC (1-acyl 16:0) were significantly
higher in the intima, media, and adventitia of VV tissues
from the C and C groups compared with controls
Fig 2. Lipid staining and quantification in vein walls. A
tissue. The phospholipid (PL) and triglyceride (TG) cont
and varicose veins from the CEAP C2-3 and C4-5 groups
error bars show the standard deviation.2-3 4-5
(P  .05; Fig 3, C). Similarly, the RRIs for PC (diacyl s6:0/20:4) were significantly higher in the intima, media,
nd adventitia of C2-3 and C4-5 VV tissues compared with
ontrols (P .05). The RRIs for TG (52:3) and TG (52:2)
n the intima and media of VV tissues were not different
rom those of CV tissues. However, the RRIs for TG (52:3)
nd TG (52:2) were significantly higher in the adventitia of
V tissues than in controls (P  .05). There were no
ignificant differences in the RRIs for TG (52:3) and TG
52:2) in any tissues between the C2-3 and C4-5 groups (Fig
, C).
Immunostaining. The vascular endothelial marker
on Willebrand factor and a marker specific for lymphatic
essels (D2-40) were applied to the control and VV tissues
or visualization of lymphatic vessels. Immunofluorescence
taining revealed that lymphatic vessels were present in the
dventitia of the GSV in controls and VV tissues (Fig 4,A).
ignificantly fewer lymphatic vessels were seen in complete
ircumferential sections in the VV groups (C2-3 and C4-5)
han in controls (P  .05; Fig 4, B).
ISCUSSION
In this study, the histopathologic changes in structural
omponents of the intima and media (such as collagen,
lastin, and smoothmuscle) of incompetent GSVs fromVV
atients are comparable to those previously reported.14-17
t has been suggested that these changes are due to chronic
nflammation in the vein tissue.14,18-20 Although we
red O staining (bar  20 m). B, Lipid content in vein
vein walls were compared among the control vein (CV)
 .05 indicates a statistically significant difference. The, Oil
ent of
. *Phowed the increased wall thickness according to the ad-
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between the vein wall thickness and the diameter, because
wall thickness varies significantly with the size of the vein.
Our previous study was the first to report the abnormal
Fig 3. Lipid content analyses by mass spectrometry.
assignedmolecule.B, Imagingmass spectrometry of vein
was compared among control veins (CV) and varicose ve
of variance, followed by the Tukey test. *P  .05 indic
statistically significant difference between the C2-3 and
deviation.accumulation of lipid molecules in incompetent valve in wVs.1 In this study, the lipid staining was limited only to
he adventitia, and not to the intima and media. We previ-
usly reported that lipid staining in the intimal and medial
egions was commonly positive in atherosclerotic tissues,21
epresentative mass spectrum pattern and spectrum of
(bar 200m).C,The ratio of intensity in vein tissues
m the CEAP C2-3 and C4-5 groups by one-way analysis
statistically significant difference. †P  .05 indicates a
aricose vein groups. The error bars show the standardA, R
tissue
ins fro
ates a
C vhich suggested the mechanism of lipid accumulation in
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rosis. The oil red O staining is a lysochrome diazo dye used
for staining of neutral TGs and lipids on frozen sections and
some lipoproteins on paraffin sections. To investigate more
details of the lipid accumulation and clarify the underlining
mechanisms, we applied MALDI-IMS. Unlike conven-
tional biochemical tests that measure lipid content in ho-
Fig 3.
Table II. Lipid molecule assignments by mass
spectrometry
Mass (m)/charge (z) Assignment of molecule
496 LPC (1-acyl 16: 0)  Na
780 PC (diacyl 16:0/18:2)  Na
782 PC (diacyl 16:0/18:1)  Na
796 PC (diacyl 16:0/18:2)  K
798 PC (diacyl 16:0/18:1)  K
804 PC (diacyl 16:0/20:4)  Na
820 PC (diacyl 16:0/20:4)  K
879 Triglyceride (52:3)  K
881 Triglyceride (52:2)  K
LPC, Lysophosphatidylcholine; PC, phosphatidylcholine.mogenized tissues or with simple oil red O staining, cALDI-IMS enables the analysis of spatial distributions or
pecific lipids, along with their fatty acid content, in regions
uch as the intima, media, and adventitia.
At present, MALDI-IMS is the only method available
or the detailed assessment of lipid molecules in tissue. This
ethod distinguishes between different lipid molecular
pecies by simultaneously determining the differences in
he mass/charge ratios (m/z).
In the present study, PC (diacyl 16:0/20:4) was ele-
ated in all three layers of VV tissues. Although the range of
iochemical effects of PC (diacyl 16:0/20:4) is uncertain,
levated levels of the molecule have been reported in mam-
alian tissues with chronic inflammation.3,4 We observed
hat PC (diacyl 16:0/20:4) contains arachidonic acid,
hich is a precursor to lipid mediators such as proinflam-
atory prostaglandins and leukotrienes. Taken together,
hese data indicate that the elevated tissue content of PC
diacyl 16:0/20:4) may be associated with chronic inflam-
ation in the incompetent GSV.
Other studies have reported the occurrence of chronic
nflammation in VV tissue.6,22 LPC (1-acyl 16:0) is known
o be a chemotactic factor for macrophages and lympho-
tinuedytes as well as an inducer of expression of both vascular cell
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May 20121446 Tanaka et aladhesion molecule-1 and intercellular adhesion molecule-1
in endothelial cells.23 Therefore, LPC (1-acyl 16:0) may
also contribute to the chronic inflammation in VV tissue.
Previous studies have highlighted the histologic
changes in the intima and media of VV tissues24,25; how-
ever, adventitial changes have not been reported. The
adventitial triglyceride accumulation in VV tissues revealed
by MALDI-IMS in this study sheds light on the pathogen-
Fig 4. Lymphatic vessel in vein wall. A, Immunofluore
(red; bar  20 m). B, Number of lymphatic vessels in c
indicates a statistically significant difference. The error baesis of the outer surface of the vein wall, which has been treviously overlooked. In Fig. 3, C, unlike LPC and PC,
G accumulation was limited to the adventitia of the VV
issue. Although LPC, PC, and TG are all lymph ingredi-
nts,26 LPC and PC are also cellular components.27,28
herefore, the elevation of LPC and PC in the intima
nd media might reflect the increase in the number of
nflammatory cells in the regions, and lymph stasis (ie,
G accumulation) might be present only in the adventi-
staining for von Willebrand Factor (green) and D2-40
lete circumferential sections from each group. *P  .05
ow the standard deviation.scent
ompial regions.
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duced in the GSV, suggesting that dysfunction of lymph
transport and subsequent lymph congestion might occur.
Because lymphatic fluid contains high concentrations of
lipid molecules, such as PC and TG, lymphatic stasis causes
tissue accumulation of lipid molecules.26,29 Taken to-
gether, the abnormal accumulation of various lipid mole-
cules may be associated with disturbances in lymph trans-
port due to the loss of lymph vessels. The association of
lymphatic dysfunction with VVs remains to be determined.
Because venodynamics and lymphodynamics interact as
an inseparable and mutually dependent dual outflow sys-
tem in tissue, the system is complex. Homeostasis can only
be maintained by a balance between the two systems. The
degeneration of VV tissue may be associated with increased
permeability, which could cause elevation of tissue pressure
and perivascular inflammation. The elevation of tissue pres-
sure induces not only lymphatic vessel dysfunction but also
structural damages to the microlymphatic networks.30
The resultant lymph stasis is associated with chronic
inflammation.31 Moreover, the inflammation due to cyto-
kines, such as tumor necrosis factor-, may induce apopto-
sis of the lymphatic vessel and decrease the number of the
vessels.32 These mixed venous and lymphatic disorders are
known as phlebolymphedema.33,34 In fact, patients with
chronic venous insufficiency have microangiopathy of the
lymphatic network.35 We used indocyanine green fluo-
rescence lymphography in a previous study to show that
the speed of lymph transportation in the lower leg was
reduced in VV patients, suggesting that secondary phle-
bolymphedema could occur in chronic venous insuffi-
ciency.36 A study that used dynamic lymphoscintigraphy in
VV patients reported a similar finding.37
The abnormal distribution of lipid molecules in VV
tissue observed in both VV groups suggests that VV-
associated accumulation of lipid molecules begins in the
early clinical stages of the disease and continues through
the advanced stages. In particular, the accumulation of
LPC (1-acyl 16:0) and PC (diacyl 16:0/20:4) in the media
was significantly higher in VV tissue from patients in ad-
vanced clinical stages, suggesting an association between
lipid accumulation and chronic inflammation of the skin
and subcutaneous tissues.
One limitation of this study was that the control veins
came from peripheral arterial disease patients, and these
veins might have been metabolically affected by the disease.
Moreover, GSV from patients with VV might have various
histochemical changes, depending on the segments,38
which would require the harvest of multiple segments of
the GSV samples for assessment of the distribution of the
lipid molecules.
Further study is needed to clarify the effect of lymph
stasis on VVs and chronic inflammation. The mechanism
whereby adventitial lymphatic vessels are damaged is also
unknown. Consistent venous hypertension and subsequent
overload to the lymphatics may account for the lymphatic
damage.30 In addition, accumulation of possible proin-ammatory lipid molecules in VVwalls may further damage
he adventitial lymphatic vessels.
ONCLUSIONS
The accumulation of LPC (1-acyl 16:0) and PC (diacyl
6:0/20:4) in VV tissue may be associated with chronic
nflammation, leading to VV tissue degeneration. More-
ver, the number of lymphatic vessels in the adventitia of
V tissue is significantly less than that of control tissue.
oss of lymphatic vessels may be associated with the accu-
ulation of lipid molecules and subsequent degeneration
f the vein wall in VVs.
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